Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-511513-37-00Phase 4Authorised
Phase 4, randomised, double-blind trial of sodium chloride and Sodium lactate in diabetic ketoacidosis (DKA) (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Resolution of ketoacidosis at 24 hours. Planned start Oct 2025; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-511513-37-00.